• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内源性心脏阿片类物质:脑啡肽在心脏适应与保护中的作用

Endogenous cardiac opioids: enkephalins in adaptation and protection of the heart.

作者信息

van den Brink Olivier W V, Delbridge Lea M, Rosenfeldt Franklin L, Penny Daniel, Esmore Donald S, Quick Deahne, Kaye David M, Pepe Salvatore

机构信息

Cardiac Surgical Research Unit Melbourne, Australia.

出版信息

Heart Lung Circ. 2003;12(3):178-87. doi: 10.1046/j.1444-2892.2003.00240.x.

DOI:10.1046/j.1444-2892.2003.00240.x
PMID:16352129
Abstract

Opiates have been used for thousands of years in the form of opium for relief of pain or fever and to induce sleep. However, it was only in the 1970s that the endogenous ligands for the opiate receptors were identified and termed opioid peptides. Opioid peptides activate G protein-coupled receptors in the central and autonomic nervous system, with marked effects on the regulation of pain perception, body temperature, respiration, heart rate and blood pressure. Cardiovascular regulatory effects of endogenous opioids were initially considered to originate from neural centres in the central nervous system, facilitating a regulatory role in neuro-transmission, as demonstrated by the presynaptic co-release from sympathetic neurones of norepinephrine with enkephalin or acetylcholine with enkephalin. However, opioid peptides of myocardial origin have also recently been shown to play a key role in local regulation of the heart. This brief review highlights the key features of the enkephalin opioids in the heart and the current understanding of their role in development, ageing, cardioprotection, hypertension, hypertrophy, and heart failure.

摘要

阿片类药物以鸦片的形式已被使用了数千年,用于缓解疼痛或发烧以及诱导睡眠。然而,直到20世纪70年代,阿片受体的内源性配体才被鉴定出来,并被称为阿片肽。阿片肽激活中枢和自主神经系统中的G蛋白偶联受体,对疼痛感知、体温、呼吸、心率和血压的调节有显著影响。内源性阿片类药物的心血管调节作用最初被认为起源于中枢神经系统的神经中枢,促进神经传递中的调节作用,如去甲肾上腺素与脑啡肽从交感神经元突触前共同释放,或乙酰胆碱与脑啡肽共同释放所证明的那样。然而,最近也表明心肌来源的阿片肽在心脏局部调节中起关键作用。这篇简短的综述强调了脑啡肽类阿片在心脏中的关键特征以及目前对它们在发育、衰老、心脏保护、高血压、肥大和心力衰竭中作用的理解。

相似文献

1
Endogenous cardiac opioids: enkephalins in adaptation and protection of the heart.内源性心脏阿片类物质:脑啡肽在心脏适应与保护中的作用
Heart Lung Circ. 2003;12(3):178-87. doi: 10.1046/j.1444-2892.2003.00240.x.
2
Cross-talk of opioid peptide receptor and beta-adrenergic receptor signalling in the heart.心脏中阿片肽受体与β-肾上腺素能受体信号的相互作用。
Cardiovasc Res. 2004 Aug 15;63(3):414-22. doi: 10.1016/j.cardiores.2004.04.022.
3
[The regulatory effects of opioid peptides--enkephalins--in controlling the activities of the cardiovascular system].[阿片肽——脑啡肽——在调控心血管系统活动中的调节作用]
Usp Fiziol Nauk. 2000 Jan-Mar;31(1):18-30.
4
The opioid system in cardiac and vascular regulation of normal and hypertensive states.阿片类系统在正常和高血压状态下心脏与血管调节中的作用
Circulation. 1987 Jan;75(1 Pt 2):I125-9.
5
[The role of the opioid system in body adaptation and protection of the heart in stress].[阿片类系统在应激状态下机体适应及心脏保护中的作用]
Usp Fiziol Nauk. 1997 Jan-Mar;28(1):75-96.
6
Opioids and opiates: analgesia with cardiovascular, haemodynamic and immune implications in critical illness.阿片类药物与鸦片制剂:在危重病中具有心血管、血流动力学及免疫影响的镇痛作用
J Intern Med. 2006 Feb;259(2):138-54. doi: 10.1111/j.1365-2796.2005.01569.x.
7
[Endogenous opioids].[内源性阿片类物质]
Tierarztl Prax. 1985;13(1):11-27.
8
Opioid receptors and preconditioning of the heart.阿片受体与心脏预处理
Rev Port Cardiol. 2004 Oct;23(10):1317-33.
9
Alterations of the preproenkephalin system in cardiac hypertrophy and its role in atrioventricular conduction.心脏肥大中前脑啡肽原系统的改变及其在房室传导中的作用。
Cardiovasc Res. 2006 Feb 1;69(2):412-22. doi: 10.1016/j.cardiores.2005.10.016. Epub 2005 Dec 22.
10
Peripherally-acting opioids.外周作用的阿片类药物。
Pain Physician. 2008 Mar;11(2 Suppl):S121-32.

引用本文的文献

1
Clinical Value of Bioactive Adrenomedullin and Proenkephalin A in Patients with Left Ventricular Assist Devices: An Observational Study.生物活性肾上腺髓质素和前脑啡肽A在左心室辅助装置患者中的临床价值:一项观察性研究。
J Clin Med. 2025 May 21;14(10):3613. doi: 10.3390/jcm14103613.
2
Association between Proenkephalin A and cardiovascular outcomes in ambulatory Veterans.前脑啡肽A与门诊退伍军人心血管结局之间的关联
Int J Cardiol Heart Vasc. 2024 Nov 16;55:101557. doi: 10.1016/j.ijcha.2024.101557. eCollection 2024 Dec.
3
Point-of-Care Serum Proenkephalin as an Early Predictor of Mortality in Patients Presenting to the Emergency Department with Septic Shock.
即时检测血清前脑啡肽作为脓毒性休克患者到急诊科就诊时死亡率的早期预测指标
Biomedicines. 2024 May 2;12(5):1004. doi: 10.3390/biomedicines12051004.
4
Proenkephalin as a biomarker correlates with acute kidney injury: a systematic review with meta-analysis and trial sequential analysis.脑啡肽原作为生物标志物与急性肾损伤相关:系统评价与荟萃分析和试验序贯分析。
Crit Care. 2023 Dec 7;27(1):481. doi: 10.1186/s13054-023-04747-5.
5
Plasma Pro-Enkephalin A and Incident Cognitive Impairment: The Reasons for Geographic and Racial Differences in Stroke Cohort.血浆前强啡肽 A 与认知障碍事件:卒中队列的地理和种族差异的原因。
J Am Heart Assoc. 2023 Jun 6;12(11):e029081. doi: 10.1161/JAHA.122.029081. Epub 2023 Jun 1.
6
New Insight in Cardiorenal Syndrome: From Biomarkers to Therapy.心肾综合征的新认识:从生物标志物到治疗。
Int J Mol Sci. 2023 Mar 7;24(6):5089. doi: 10.3390/ijms24065089.
7
Proenkephalin as a Novel Prognostic Marker in Heart Failure Patients: A Systematic Review and Meta-Analysis.脑啡肽原作为心力衰竭患者的新型预后标志物:系统评价和荟萃分析。
Int J Mol Sci. 2023 Mar 3;24(5):4887. doi: 10.3390/ijms24054887.
8
Advances in laboratory detection of acute kidney injury.急性肾损伤实验室检测的进展
Pract Lab Med. 2022 Jun 2;31:e00283. doi: 10.1016/j.plabm.2022.e00283. eCollection 2022 Aug.
9
CIRBP-OGFR axis safeguards against cardiomyocyte apoptosis and cardiotoxicity induced by chemotherapy.CIRBP-OGFR 轴可防止化疗引起的心肌细胞凋亡和心脏毒性。
Int J Biol Sci. 2022 Apr 11;18(7):2882-2897. doi: 10.7150/ijbs.69655. eCollection 2022.
10
Is high sensitive-troponin I a reliable biomarker for cardiac injury in methadone toxicity? A prospective cross-sectional study.高敏肌钙蛋白 I 是阿片类药物中毒性心脏损伤的可靠生物标志物吗?一项前瞻性的横断面研究。
BMC Pharmacol Toxicol. 2022 Mar 23;23(1):17. doi: 10.1186/s40360-022-00558-6.